Products Categories
CAS No.: | 4368-28-9 |
---|---|
Name: | TETRODOTOXIN |
Article Data: | 3 |
Molecular Structure: | |
Formula: | C11H17N3O8 |
Molecular Weight: | 319.271 |
Synonyms: | 8a(1H)-Quinazolineorthoglycolicacid, octahydro-4,5,6,7,8-pentahydroxy-6-(hydroxymethyl)-2-imino-, cyclic8a,5:8a,7-ester (7CI);Tetrodotoxin (8CI);(-)-Tetrodotoxin;5,9:7,10a-Dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol,octahydro-12-(hydroxymethyl)-2-imino-, [4R-(4a,4aa,5a,7a,9a,10a,10ab,11S*,12S*)]-;Araregai toxin;BJT 1;Babyloniajaponica toxin 1;Maculotoxin;PFT-1 Toxin;Spheroidine;TTX;Tarichatoxin;Tetrodotoxine;[4R-(4a,4aa,5a,7a,9a,10a,10ab,11S*,12S*)]-Octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol; |
EINECS: | 224-458-8 |
Density: | 2.78 g/cm3 |
Melting Point: | 225oC dec |
Boiling Point: | 702.6 °C at 760 mmHg |
Flash Point: | 378.7 °C |
Solubility: | slightly soluble in Water |
Appearance: | white powder |
Hazard Symbols: | T+ |
Risk Codes: | 26/27/28 |
Safety: | 22-36/37/39-45 |
Transport Information: | UN 3462 6.1/PG 1 |
PSA: | 192.32000 |
LogP: | -6.03400 |
tetradotoxin
Conditions | Yield |
---|---|
With palladium 10% on activated carbon; hydrogen In methanol at 20℃; for 3h; | 96.4% |
Conditions | Yield |
---|---|
In water-d2; trifluoroacetic acid for 96h; | A 66% B 15% |
tetradotoxin
Conditions | Yield |
---|---|
In water-d2; trifluoroacetic acid for 96h; | 63% |
Conditions | Yield |
---|---|
With trifluoroacetic acid In water at 20℃; | A 58% B 36% |
tetradotoxin
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: HgCl2; Et3N / dimethylformamide / 20 °C 2: 36 percent / trifluoroacetic acid / H2O / 20 °C View Scheme |
Acetic acid (1R,3S,5S,6S,7S,8R,9S,10S)-9-acetoxy-9-acetoxymethyl-8-dimethoxymethyl-3,10-dihydroxy-7-(2,2,2-trichloro-acetylamino)-2,4-dioxa-tricyclo[3.3.1.13,7]dec-6-yl ester
tetradotoxin
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: 2,6-lutidine / CH2Cl2 / 0 °C 2: diisobutylaluminum hydride / CH2Cl2 / -40 °C 3: HgCl2; Et3N / dimethylformamide / 20 °C 4: 36 percent / trifluoroacetic acid / H2O / 20 °C View Scheme |
2,2,2-Trichloro-N-[(1R,2S,5R,6S)-2-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-4-methyl-5,6-bis-triethylsilanyloxy-1-vinyl-cyclohex-3-enyl]-acetamide
tetradotoxin
Conditions | Yield |
---|---|
Multi-step reaction with 16 steps 1.1: selenium dioxide; pyridine N-oxide / dioxane / Heating 1.2: 48 percent / NaBH4; CeCl3*7H2O / methanol / 0 °C 2.1: 2,6-lutidine / CH2Cl2 / 0 °C 2.2: 83 percent / m-chloroperbenzoic acid; Na2HPO4 / CH2Cl2 / 20 °C 3.1: 90 percent / O3; Et3N / CH2Cl2 / -78 °C 4.1: 70 percent / EtMgBr / tetrahydrofuran / 0 °C 5.1: 4-dimethylaminopyridine / pyridine / 20 °C 5.2: 91 percent / tetrabutylammonium fluoride / tetrahydrofuran / -10 °C 6.1: KMnO4; NaIO4; NaHCO3 / 2-methyl-propan-2-ol; H2O / 50 °C 7.1: H2O2; NaHCO3 / methanol / 20 °C 8.1: 2,6-lutidine / CH2Cl2 / -40 °C 9.1: pyridine / 20 °C 10.1: tetrabutylammonium fluoride / acetonitrile / 0 °C 10.2: 71 percent / pyridine / 20 °C 11.1: periodic acid / methyl acetate / 20 °C 11.2: camphor sulfonic acid / methanol / 20 °C 12.1: aq. NH3 / methanol / 0 °C 13.1: 2,6-lutidine / CH2Cl2 / 0 °C 14.1: diisobutylaluminum hydride / CH2Cl2 / -40 °C 15.1: HgCl2; Et3N / dimethylformamide / 20 °C 16.1: 36 percent / trifluoroacetic acid / H2O / 20 °C View Scheme |
C25H36Cl3NO12Si
tetradotoxin
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: diisobutylaluminum hydride / CH2Cl2 / -40 °C 2: HgCl2; Et3N / dimethylformamide / 20 °C 3: 36 percent / trifluoroacetic acid / H2O / 20 °C View Scheme |
Acetic acid (1R,3S,5S,6S,7R,8R,9S,10S)-3,6,9-triacetoxy-9-acetoxymethyl-8-dimethoxymethyl-7-(2,2,2-trichloro-acetylamino)-2,4-dioxa-tricyclo[3.3.1.13,7]dec-10-yl ester
tetradotoxin
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: aq. NH3 / methanol / 0 °C 2: 2,6-lutidine / CH2Cl2 / 0 °C 3: diisobutylaluminum hydride / CH2Cl2 / -40 °C 4: HgCl2; Et3N / dimethylformamide / 20 °C 5: 36 percent / trifluoroacetic acid / H2O / 20 °C View Scheme |
2,2,2-Trichloro-N-[(1R,2S,5R,6S)-2-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-4-hydroxymethyl-5,6-bis-triethylsilanyloxy-1-vinyl-cyclohex-3-enyl]-acetamide
tetradotoxin
Conditions | Yield |
---|---|
Multi-step reaction with 15 steps 1.1: 2,6-lutidine / CH2Cl2 / 0 °C 1.2: 83 percent / m-chloroperbenzoic acid; Na2HPO4 / CH2Cl2 / 20 °C 2.1: 90 percent / O3; Et3N / CH2Cl2 / -78 °C 3.1: 70 percent / EtMgBr / tetrahydrofuran / 0 °C 4.1: 4-dimethylaminopyridine / pyridine / 20 °C 4.2: 91 percent / tetrabutylammonium fluoride / tetrahydrofuran / -10 °C 5.1: KMnO4; NaIO4; NaHCO3 / 2-methyl-propan-2-ol; H2O / 50 °C 6.1: H2O2; NaHCO3 / methanol / 20 °C 7.1: 2,6-lutidine / CH2Cl2 / -40 °C 8.1: pyridine / 20 °C 9.1: tetrabutylammonium fluoride / acetonitrile / 0 °C 9.2: 71 percent / pyridine / 20 °C 10.1: periodic acid / methyl acetate / 20 °C 10.2: camphor sulfonic acid / methanol / 20 °C 11.1: aq. NH3 / methanol / 0 °C 12.1: 2,6-lutidine / CH2Cl2 / 0 °C 13.1: diisobutylaluminum hydride / CH2Cl2 / -40 °C 14.1: HgCl2; Et3N / dimethylformamide / 20 °C 15.1: 36 percent / trifluoroacetic acid / H2O / 20 °C View Scheme |
MF: C11H17N3O8
MW: 319.27
EINECS: 224-458-8
Product Categories: Living creature toxin;Sodium channel
Mol File: 4368-28-9.mol
storage temp: 2-8°C
solubility: H2O: stable at pH 4-5 if stored frozensoluble
form: powder
color: white
Merck: 13,9318
Synonyms:FUGU POISON;TTX;TETRODOTOXIN;TETRODOTOXIN, FUGU SPECIES;OCTAHYDRO-12-(HYDROXYMETHYL)-2-IMINO-5,9:7,10A-DIMETHANO-10AH-[1,3]DIOXOCINO[6,5-D]PYRIMIDINE-4,7,10,11,12-PENTOL;10abeta,11s*,12s*))-10alph;12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10ah-(1,3)dioxocino(6,5-d)pyri;4aalpha,5alpha,7alpha,9alpha,10alpha,10abeta,11s*,12s*))-octahydro-(4r-(4alph
The structure of FUGU POISON is:
1. | orl-mus LD50:435 µg/kg | JJPAAZ Japanese Journal of Pharmacology. 17 (1967),267. | ||
2. | ipr-mus LD50:8 µg/kg | SCIEAS Science. 144 (1964),1100. | ||
3. | scu-mus LD50:8 µg/kg | CTOXAO Clinical Toxicology. 4 (1971),331. | ||
4. | ivn-mus LD50:9 µg/kg | JJPAAZ Japanese Journal of Pharmacology. 17 (1967),267. |